Pluspunten
HR does an amazing job at keeping up the company culture. There are programs in the pipeline and drugs that are very soon to be in clinical 2 phase. I am certain that 2022-2023 will be a pivotal year for Compass. It is a great time to join this stable and growing company while other biotech’s are faltering amidst the economic turndown. The people make this company and Compass continues to invest in its people and teams. Another great quality is transparency and open communication of the state of the company, especially within recruiting and talent management.
Minpunten
I see a positive shift of Sr Management hiring highly skilled G&A and R&D staff; as well as taking the time to create relationships. Sr Management is developing trust in their teams to be direct and creative in their roles. The only con is there could be more engagement to further develop professional relationships cross-functionally.